$1.28
▼ -1.9% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
MAIA Biotechnology Says Ateganosine Shows 90.5% Disease Control Rate in Phase 2 Expansion Trial
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
MAIA Biotechnology Completes Part C International Enrollment for Phase 2 Ateganosine Trial
Overview
52-week range
$0.87
$3.19
18% of range
Avg surprise (last 3)
+19.4%
Avg reaction (last 2)
+1.7%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.14 | $-0.18 | +22.2% | +12.5% | -0.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.27 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.18 | $-0.24 | +25.0% | — | — | earnings |
| Fri May 9, 2025 | Mar/2025 | $-0.16 | $-0.18 | +11.1% | — | +4.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.40 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.46 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.36 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.35 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.11 | -$0.18 | +38.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-7M | — | $-9M | $-5M | $-5M | — | $-4M | $-4M |
| Net income | $-6M | — | $-9M | $-5M | $-5M | — | $-3M | $-9M |
| EPS (diluted) | $-0.14 | — | $-0.27 | $-0.18 | $-0.16 | — | $-0.11 | $-0.40 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $35M | $10M | $12M | $11M | $12M | $10M | $9M | $12M |
| Total assets | $35M | $10M | $12M | $11M | $12M | $10M | $9M | $12M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $7M | $12M | $7M | $7M | $7M | $8M | $9M |
| Total equity | $28M | $2M | $41,670 | $4M | $5M | $4M | $2M | $3M |
Implied volatility — last 90 days
No IV snapshots yet for MAIA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.